ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extensionLaura M. Gault, Weining Robieson, Yili Pritchett et al.|Alzheimer s Research & Therapy|2016Cited by 39